Cardiologists claim success with growth factor therapy
This article was originally published in Clinica
Executive Summary
Growth factor therapy sustained over time appears to be an effective way to revascularise the heart and could be an alternative to bypass surgery, and even newer techniques such as laser revascularisation (TMR), in patients with severe angina. In addition, the treatment appears safe and free of side-effects, according to a double blind, randomised, controlled study reported in the November 2 edition of Circulation.
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.